Compounds > bromocriptine
Page last updated: 2024-08-23

bromocriptine and guanfacine

bromocriptine has been researched along with guanfacine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Klijn, JG; Lamberts, SW; Stefanko, SZ; van Vroonhoven, CC1
Aarts, E; D'Esposito, M; Gratton, C; Silver, MA; Wallace, DL; Yousef, S1

Reviews

1 review(s) available for bromocriptine and guanfacine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for bromocriptine and guanfacine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    The Journal of clinical endocrinology and metabolism, 1985, Volume: 60, Issue:6

    Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Growth Hormone; Guanfacine; Guanidines; Humans; Immunochemistry; Middle Aged; Phenylacetates; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone

1985
Cholinergic, But Not Dopaminergic or Noradrenergic, Enhancement Sharpens Visual Spatial Perception in Humans.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2017, 04-19, Volume: 37, Issue:16

    Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Bromocriptine; Cholinesterase Inhibitors; Contrast Sensitivity; Donepezil; Dopamine Agonists; Female; Guanfacine; Humans; Indans; Male; Piperidines; Random Allocation; Visual Cortex

2017